UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Efficacy of a Flat Low Dose of Nivolumab in Advanced Cancer: A Retrospective Case Series

Anticancer research, 2022-03, Vol.42 (3), p.1433-1437

2022

Link zum Volltext

Verfügbarkeit prüfen

Second generation Spautin-1 analogues targeting EGFR-mutant non-small cell lung cancer cells

Bioorganic & medicinal chemistry letters, 2023-01, Vol.79, p.129066-129066, Article 129066

2023

Link zum Volltext

Verfügbarkeit prüfen

Performance of Two Geriatric Screening Tools in Older Patients With Cancer

Journal of clinical oncology, 2014-01, Vol.32 (1), p.19-26

2014

Link zum Volltext

Verfügbarkeit prüfen

The relationship between vagal nerve activity and clinical outcomes in prostate and non-small cell lung cancer patients

Oncology reports, 2013-11, Vol.30 (5), p.2435-2441

2013

Link zum Volltext

Verfügbarkeit prüfen

miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells

PloS one, 2013-03, Vol.8 (3), p.e60317-e60317

2013

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a comprehensive rehabilitation program for post-treatment patients with cancer

Oncology nursing forum, 2011-11, Vol.38 (6), p.E418

2011

Link zum Volltext

Verfügbarkeit prüfen

Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval

Journal of clinical oncology, 2010-05, Vol.28 (15), p.2512-2519

2010

Link zum Volltext

Verfügbarkeit prüfen

The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety

Familial cancer, 2016-04, Vol.15 (2), p.155-162

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Journal of clinical oncology, 2006-09, Vol.24 (26), p.4293-4300

2006

Link zum Volltext

Verfügbarkeit prüfen

Non-V600 BRAF mutations recurrently found in lung cancer predict sensitivity to the combination of Trametinib and Dabrafenib

Oncotarget, 2017-09, Vol.8 (36), p.60094-60108

2017

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic potential of the vagus nerve in cancer

Immunology letters, 2018-10, Vol.202, p.38-43

2018

Link zum Volltext

Verfügbarkeit prüfen

Nutrition therapy in cachectic cancer patients. The Tight Caloric Control (TiCaCo) pilot trial

Appetite, 2015-08, Vol.91, p.298-301

2015

Link zum Volltext

Verfügbarkeit prüfen

USP13 controls the stability of Aurora B impacting progression through the cell cycle

Oncogene, 2020-09, Vol.39 (37), p.6009-6023

2020

Link zum Volltext

Verfügbarkeit prüfen

The added value of geriatric screening and assessment for predicting overall survival in older patients with cancer

Cancer, 2018-09, Vol.124 (18), p.3753-3763

2018

Link zum Volltext

Verfügbarkeit prüfen

The genomic landscape of nonsmall cell lung carcinoma in never smokers

International journal of cancer, 2020-06, Vol.146 (11), p.3207-3218

2020

Link zum Volltext

Verfügbarkeit prüfen

Targeting USP13‐mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non‐small cell lung cancer

International journal of cancer, 2021-05, Vol.148 (10), p.2579-2593

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab

BMC medicine, 2012-03, Vol.10 (1), p.28-28, Article 28

2012

Link zum Volltext

Verfügbarkeit prüfen

Retrospective comparison of two consecutive cohorts of adjuvant chemotherapy regimens of cyclophosphamide with either docetaxel or paclitaxel in older patients with early breast cancer

The breast journal, 2019-07, Vol.25 (4), p.663-666

2019

Link zum Volltext

Verfügbarkeit prüfen

De novo Alu element insertions targeted to a sequence common to the BRCA1 and BRCA2 genes

Human mutation, , Vol.26 (3), p.284-284

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of PLK1 Destabilizes EGFR and Sensitizes EGFR-Mutated Lung Cancer Cells to Small Molecule Inhibitor Osimertinib

Cancers, 2023-05, Vol.15 (9), p.2589

2023

Link zum Volltext

Verfügbarkeit prüfen

Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families

BMC cancer, 2019-04, Vol.19 (1), p.313-313, Article 313

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of siRNAs targeting the EGFR T790M mutation in a non-small cell lung cancer cell line resistant to EGFR tyrosine kinase inhibitors and combination with various agents

Biochemical and biophysical research communications, 2013-02, Vol.431 (3), p.623-629

2013

Link zum Volltext

Verfügbarkeit prüfen

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

Cell death & disease, 2022-07, Vol.13 (7), p.611-611, Article 611

2022

Link zum Volltext

Verfügbarkeit prüfen

The prognostic value of 3 commonly measured blood parameters and geriatric assessment to predict overall survival in addition to clinical information in older patients with cancer

Cancer, 2018-09, Vol.124 (18), p.3764-3775

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 205

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(178)
Mit Volltextzugriff
(187)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy of a Flat Low Dose of Nivolumab in Advanced Cancer: A Retrospective Case Series

Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT)

Second generation Spautin-1 analogues targeting EGFR-mutant non-small cell lung cancer cells

Performance of Two Geriatric Screening Tools in Older Patients With Cancer

The relationship between vagal nerve activity and clinical outcomes in prostate and non-small cell lung cancer patients

miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells

Evaluation of a comprehensive rehabilitation program for post-treatment patients with cancer

Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval

The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety

Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Non-V600 BRAF mutations recurrently found in lung cancer predict sensitivity to the combination of Trametinib and Dabrafenib

Therapeutic potential of the vagus nerve in cancer

Nutrition therapy in cachectic cancer patients. The Tight Caloric Control (TiCaCo) pilot trial

USP13 controls the stability of Aurora B impacting progression through the cell cycle

The added value of geriatric screening and assessment for predicting overall survival in older patients with cancer

The genomic landscape of nonsmall cell lung carcinoma in never smokers

Targeting USP13‐mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non‐small cell lung cancer

Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab

Retrospective comparison of two consecutive cohorts of adjuvant chemotherapy regimens of cyclophosphamide with either docetaxel or paclitaxel in older patients with early breast cancer

De novo Alu element insertions targeted to a sequence common to the BRCA1 and BRCA2 genes

Inhibition of PLK1 Destabilizes EGFR and Sensitizes EGFR-Mutated Lung Cancer Cells to Small Molecule Inhibitor Osimertinib

Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families

Effect of siRNAs targeting the EGFR T790M mutation in a non-small cell lung cancer cell line resistant to EGFR tyrosine kinase inhibitors and combination with various agents

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

The prognostic value of 3 commonly measured blood parameters and geriatric assessment to predict overall survival in addition to clinical information in older patients with cancer

Suchergebnisse filtern